CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
Enstilardrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03848871
NCT03848871Phase 4Completed
CompareCT.gov

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Derm Research, PLLC·interventional·Posted Feb 21, 2019·Updated Aug 26, 2020

In Brief

A Phase 4 clinical trial evaluating Enstilar for Plaque Psoriasis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This study seeks to show whether there is a benefit of prescribing Enstilar in the treatment of patients with moderate plaque type psoriasis. Subjects will receive study treatment of Enstilar foam.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedFeb 21, 2019
Enrollment StartDec 12, 2017
Primary CompletionNov 30, 2018
Study CompletionDec 10, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.4 years ago

Interventions

Enstilardrug

Enstilar foam applied to affected area once daily